Heart and Mind,
Journal Year:
2023,
Volume and Issue:
7(4), P. 235 - 245
Published: Oct. 1, 2023
Background:
The
multisystem
associations
between
baseline
mental
health
status
and
coronavirus
disease-19
(COVID)-19
illness
trajectory
are
uncertain.
Objectives:
This
article
will
investigate
the
disease
following
COVID-19
hospitalization,
which
may
have
implications
for
practice
future
research.
Methods:
Chief
Scientist
Office
Cardiovascular
Pulmonary
Imaging
in
severe
acute
respiratory
syndrome
(SARS)
study
is
a
prospective,
observational,
multicenter,
longitudinal,
secondary
care
cohort
that
assessed
time-course
of
multi-organ
injury
posthospital
survivors
COVID-19.
Patients
were
in-hospital,
at
28–60
days
after
discharge
longer
term
using
electronic
record
linkage.
Results:
One
hundred
fifty-two
patients
(mean
±
standard
deviation
[SD]
age
54.3
11.8
years,
43%
female,
40%
most
socio-economically
deprived
quintile,
33%
history
history)
enrolled
had
serially
Patient
Health
Questionnaire-4
(PHQ-4)
questionnaire.
Fifty-three
(35%)
PHQ-4
score
6–12
consistent
with
moderate-severe
symptoms
anxiety
or
depression
this
was
associated
diagnostic
criteria
myocarditis
(
P
=
0.0498).
Moderate-severe
positively
higher
perception
illness,
lower
health-related
quality
life
(HRQoL),
poorer
physical
function.
mean
(SD)
duration
follow-up
hospital
428
(86)
(range,
290–627
days).
not
clinical
outcomes
follow-up.
Conclusions:
In
who
been
hospitalized
COVID-19,
myocarditis,
worse
HRQoL,
levels
Public
Registration:
ClinicalTrials.gov
identifier
NCT04403607.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 421 - 421
Published: Feb. 10, 2025
In
the
years
following
global
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
or
COVID-19,
researchers
have
become
acutely
aware
long-term
symptomology
associated
with
this
disease,
often
termed
long
COVID.
Long
COVID
is
pervasive
symptoms
affecting
multiple
organ
systems.
Neurocognitive
are
reported
by
up
to
40%
patients,
resultant
effects
loss
daily
functioning,
employment
issues,
and
enormous
economic
impact
high
healthcare
utilization.
The
literature
on
effective,
safe,
non-invasive
interventions
for
remediation
cognitive
consequences
scarce
poorly
described.
Of
specific
interest
narrative
review
identification
potential
COVID-associated
neurocognitive
deficits.
Articles
were
sourced
from
PubMed,
EBSCO,
Scopus,
Embase
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines.
published
between
dates
January
2020
30
June
2024
included
in
search.
Twelve
studies
review,
including
a
feasibility
study,
pilot
case
series,
an
observational
addition
three
randomized
clinical
trials
four
interventional
studies.
Overall,
treatment
such
as
training,
brain
stimulation
therapy,
exercise
rehabilitation,
targeted
pharmacological
intervention,
other
related
paradigms
show
promise
reducing
issues.
This
highlights
need
more
rigorous
experimental
designs
future
needed
fully
evaluate
persistent
deficits
Frontiers in Cellular Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: Feb. 12, 2025
Cognitive
impairment
is
one
of
the
many
symptoms
reported
by
individuals
suffering
from
long-COVID
and
other
post-viral
infection
disorders
such
as
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
A
common
factor
among
these
conditions
a
sustained
immune
response
increased
levels
inflammatory
cytokines.
Tumor
necrosis
alpha
(TNF-α)
interleukin-6
(IL-6)
are
two
cytokines
that
elevated
in
patients
diagnosed
with
ME/CFS.
In
this
study,
we
characterized
changes
neural
functionality,
secreted
cytokine
profiles,
gene
expression
co-cultures
human
iPSC-derived
neurons
primary
astrocytes
to
prolonged
exposure
TNF-α
IL-6.
We
found
produced
both
concentration-independent
concentration-dependent
activity.
Burst
duration
was
significantly
reduced
within
few
days
regardless
concentration
(1
pg/mL
–
100
ng/mL)
but
returned
baseline
after
7
days.
Treatment
low
concentrations
(e.g.,
1
25
pg/mL)
did
not
lead
profile
or
still
resulted
significant
electrophysiological
features
interspike
interval
burst
duration.
Conversely,
treatment
high
10
led
spiking
activity,
which
may
be
correlated
health,
expression,
increases
secretion
IL-1β,
IL-4,
CXCL-10)
were
observed
at
higher
concentrations.
Prolonged
IL-6
bursting
features,
reduction
number
spikes
bursts
across
wide
range
(i.e.,
pg/mL–10
ng/mL).
combination,
addition
appears
counteract
function
induced
TNF-α,
while
had
little
no
effect.
lost
when
cultures
co-stimulated
concentration,
suggesting
play
more
pronounced
role
altering
function.
These
results
indicate
key
associated
can
directly
impact
component
cognitive
disorders.
Bioelectronic Medicine,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Feb. 27, 2025
Abstract
Background
Following
the
COVID-19
pandemic,
there
are
many
chronically
ill
Long
COVID
(LC)
patients
with
different
symptoms
of
varying
degrees
severity.
The
pathological
pathways
LC
remain
unclear
until
recently
and
make
identification
path
mechanisms
exploration
therapeutic
options
an
urgent
challenge.
There
is
apparent
relationship
between
impaired
cholinergic
neurotransmission.
Methods
This
paper
reviews
current
literature
on
effects
blocked
nicotinic
acetylcholine
receptors
(nAChRs)
main
affected
organ
cell
systems
contrasts
this
unblocking
alkaloid
nicotine.
In
addition,
presented
that
could
explain
previously
unexplained
phenomenon
post-vaccination
syndrome
(PVS).
fact
not
only
SARS-CoV-2
but
numerous
other
viruses
can
bind
to
nAChRs
discussed
under
assumption
post-viral
diseases
autoimmune
(ADs)
may
also
be
due
transmission.
We
present
a
case
report
demonstrates
changes
in
transmission,
specifically,
availability
α4β2
by
using
(-)-[
18
F]Flubatine
whole-body
positron
emission
tomography
(PET)
imaging
dysfunction
patient
along
significant
neurological
improvement
before
after
low-dose
transcutaneous
nicotine
(LDTN)
administration.
Lastly,
descriptive
analysis
evaluation
were
conducted
results
survey
involving
231
users
LDTN.
Results
A
substantial
body
research
has
emerged
offers
compelling
explanation
for
LC,
suggesting
it
plausibly
explained
because
nAChR
function
human
body.
ten-day
course
administration,
no
enduring
neuropathological
manifestations
observed
patient.
observation
was
accompanied
increase
number
free
ligand
binding
sites
(LBS)
nAChRs,
as
determined
PET
imaging.
shows
majority
(73.5%)
their
LC/MEF/CFS
disease
result
Conclusions
conclusion,
based
knowledge,
LDTN
appears
promising
safe
procedure
relieve
expected
long-term
harm.
Exploration of neuroscience,
Journal Year:
2025,
Volume and Issue:
4
Published: March 24, 2025
The
SAR-CoV-2
virus
has
evolved
to
co-exist
with
human
hosts,
albeit
at
a
substantial
energetic
cost
resulting
in
post-infection
neurological
manifestations
[Neuro-post-acute
sequelae
of
SARS-CoV-2
infection
(PASC)]
that
significantly
impact
public
health
and
economic
productivity
on
global
scale.
One
the
main
molecular
mechanisms
responsible
for
development
Neuro-PASC,
individuals
all
ages,
is
formation
inadequate
proteolysis/clearance
phase-separated
amyloid
crystalline
aggregates—a
hallmark
feature
aging-related
neurodegenerative
disorders.
Amyloidogenesis
during
viral
persistence
natural,
inevitable,
protective
defense
response
exacerbated
by
SARS-CoV-2.
Acting
as
chemical
catalyst,
accelerates
hydrophobic
collapse
heterogeneous
nucleation
amorphous
amyloids
into
stable
β-sheet
aggregates.
clearance
aggregates
most
effective
slow
wave
sleep,
when
high
levels
adenosine
triphosphate
(ATP)—a
biphasic
modulator
biomolecular
condensates—and
melatonin
are
available
solubilize
removal.
dysregulation
mitochondrial
dynamics
SARS-CoV-2,
particular
fusion
fission
homeostasis,
impairs
proper
distinct
subpopulations
can
remedy
challenges
created
diversion
substrates
away
from
oxidative
phosphorylation
towards
glycolysis
support
replication
maintenance.
subsequent
reduction
ATP
inhibition
synthesis
sleep
results
incomplete
brain
aggregates,
leading
commonly
associated
age-related
Exogenous
not
only
prevents
dysfunction
but
also
elevates
production,
effectively
augmenting
solubilizing
effect
moiety
ensure
timely,
optimal
disaggregation
pathogenic
prevention
attenuation
Neuro-PASC.
Neurorehabilitation,
Journal Year:
2025,
Volume and Issue:
56(1), P. 37 - 47
Published: Feb. 1, 2025
The
proposed
study
reports
the
design
and
development
of
a
rapid
screening
tool,
Systems
Neuroscience
Test
Battery
(SNTB),
for
diagnosing
evaluating
neurological
manifestations
Post-COVID-19
Neurological
Syndrome
(PCNS)
within
broader
context
Post-Acute
Sequelae
to
COVID-19
(PASC).
SNTB
is
designed
incorporate
behaviorally
relevant
Telehealth
component
that
enhances
consumer
confidence
in
symptom
discrimination,
management
PCNS,
guides
rehabilitation
programs
while
allowing
continuous
evaluation
intervention
effectiveness.
employs
longitudinal
design,
with
telehealth
routine
blood
assessments
conducted
at
three-month
intervals,
including
least
two
follow-ups
post-recruitment.
These
will
involve
Consumer-Reported
Symptoms,
Clinical
History,
Neuropsychological
Data,
Timed
Psychophysics,
aimed
PCNS-related
symptoms
‘brain
fog”
its
affect
on
visually
driven
attention,
cognition
motor
behaviors.
are
intended
validate
characteristics
fog’
identify
predictive
behavioral
biomarkers
PCNS.
target
population
includes
adults
aged
18–65
who
have
experienced
persistent
three
months
following
confirmed
infection.
Exclusion
criteria
include
individuals
unable
undergo
radiological
examinations,
such
as
pregnant
women
or
those
contraindications
MRI,
ensuring
robustness
sample
reducing
potential
selection
bias.
tool
facilitate
online
identification
PCNS
aid
discovery
effective
molecular
biomarker
combinations
medical
rehabilitation.
Complementary
Assessment,
hospital
facilities
be
utilized
blood-based
assessments,
concurrent
profiling
structural
functional
changes
during
recovery
from
symptoms.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(2), P. 332 - 332
Published: Feb. 4, 2024
Coronavirus
disease
2019
(COVID-19)
caused
a
severe
epidemic
due
to
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2).
Recent
studies
have
found
that
patients
do
not
completely
recover
from
infections,
but
instead,
suffer
variety
of
post-acute
sequelae
SARS-CoV-2
infection,
known
as
long
COVID.
The
effects
COVID
can
be
far-reaching,
with
duration
up
six
months
and
range
symptoms
such
cognitive
dysfunction,
immune
dysregulation,
microbiota
dysbiosis,
myalgic
encephalomyelitis/chronic
fatigue
syndrome,
myocarditis,
pulmonary
fibrosis,
cough,
diabetes,
pain,
reproductive
thrombus
formation.
However,
recent
shown
naringenin
naringin
palliative
on
various
COVID-19
sequelae.
Flavonoids
naringenin,
commonly
in
fruits
vegetables,
positive
effects,
including
reducing
inflammation,
preventing
viral
providing
antioxidants.
This
article
discusses
the
molecular
mechanisms
clinical
treating
above
diseases.
It
proposes
them
potential
drugs
for
treatment
COVID,
it
inferred
exhibit
extended
medications,
future
likely
serving
nutraceuticals
or
supplements
comprehensive
alleviation
manifestations
complications.
Reviews in Medical Virology,
Journal Year:
2024,
Volume and Issue:
34(6)
Published: Nov. 1, 2024
Abstract
The
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
in
December
2019
triggered
a
swift
global
spread,
leading
to
devastating
pandemic.
Alarmingly,
approximately
one
four
individuals
diagnosed
with
disease
(COVID‐19)
experience
varying
degrees
cognitive
impairment,
raising
concerns
about
potential
increase
neurological
sequelae
cases.
Neuroinflammation
seems
be
the
key
pathophysiological
hallmark
linking
mild
COVID‐19
fatigue,
and
patients,
highlighting
interaction
between
nervous
immune
systems
following
SARS‐CoV‐2
infection.
Several
hypotheses
have
been
proposed
explain
how
virus
disrupts
physiological
pathways
trigger
inflammation
within
CNS,
potentially
neuronal
damage.
These
include
neuroinvasion,
systemic
inflammation,
disruption
lung
gut‐brain
axes,
reactivation
latent
viruses.
This
review
explores
origins
neuroinflammation
underlying
neuroimmune
cross‐talk,
important
unanswered
questions
field.
Addressing
these
fundamental
issues
could
enhance
our
understanding
virus's
impact
on
CNS
inform
strategies
mitigate
its
detrimental
effects.
Cardiopulmonary Physical Therapy Journal,
Journal Year:
2024,
Volume and Issue:
36(1), P. 39 - 49
Published: Dec. 30, 2024
Long
COVID
is
a
disabling
condition
which
affects
occupational
performance
and
quality
of
life.
It
interferes
with
activities
daily
living,
work,
many
meaningful
life
roles.
Cognitive
dysfunction
frequently
reported
symptom,
yet
it
commonly
overlooked.
important
that
cognitive
activity
considered
when
working
people
long
COVID,
particularly
identifying
triggers
post
exertional
symptom
exacerbation.
There
are
potential
mechanisms
could
be
driving
in
including
neuroinflammation,
viral
persistence,
vascular
damage,
orthostatic
intolerance.
to
consider
these
help
guide
intervention.
The
purpose
this
clinical
perspective
highlight
the
debilitating
impact
those
share
key
role
therapists
area.
may
missed
on
standardized
assessments
as
they
not
sensitive
enough
due
episodic
nature
symptoms.
Occupational
can
play
area
experts
assessing
providing
safe
assessment
rehabilitation.
Journal of Cardiovascular Electrophysiology,
Journal Year:
2023,
Volume and Issue:
35(3), P. 608 - 617
Published: Oct. 25, 2023
Abstract
Coronavirus
disease
2019
(COVID‐19)
has
led
to
a
worldwide
pandemic
that
continues
transform
but
will
not
go
away.
Cardiovascular
dysautonomia
in
postacute
sequelae
of
severe
acute
respiratory
syndrome
coronavirus
2
infection
persistent
symptoms
large
number
patients.
Here,
we
define
the
condition
and
its
associated
as
well
potential
mechanisms
responsible.
We
provide
careful
complete
overview
topic
addressing
novel
studies
generalized
approach
management
individuals
with
this
complex
potentially
debilitating
problem.
also
discuss
future
research
directions
important
knowledge
gaps
be
addressed
ongoing
planned
studies.